News Quantified

VSTM – verastem, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Verastem Oncology to Present at the 8th Annual Evercore Healthcare Conference

Verastem (NASDAQ:VSTM) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.

Verastem Oncology Announces Pricing of $90 Million Public Offering of Common Stock and Pre-Funded Warrants

Verastem Oncology to Present at Upcoming Investor Conferences

Verastem, Inc. (VSTM) Q3 2025 Earnings Call Transcript [Seeking Alpha]

-14.6%

MISS

19.9%

MISS

-3.4%

MISS

Cantor Fitzgerald

Cantor Fitzgerald

Cantor Fitzgerald

Form 4 Verastem, Inc. For: Dec 02 Filed by: Paterson Dan

Form 4 Verastem, Inc. For: Nov 26 Filed by: Paterson Dan

Form 4 Verastem, Inc. For: Nov 21 Filed by: Bunn Paul A.

Form 4 Verastem, Inc. For: Nov 21 Filed by: Kauffman Michael

Form 4 Verastem, Inc. For: Nov 21 Filed by: Paterson Dan

Top News Gainers

2/28 Verastem Oncology Announces New Strategic Direction to Advance Its Clinical Development Programs 59.4%

1/8 Verastem Oncology Announces Global Licensing Agreement with Chugai Pharmaceutical Co., Ltd. to Develop and Commercialize RAF/MEK Inhibitor CH5126766 43.3%

6/17 Verastem Oncology Presents COPIKTRA™ (Duvelisib) Data at the European Hematology Association 2019 Annual Meeting 24.1%

10/23 Verastem Oncology Announces COPIKTRA™ (Duvelisib) Presentations at the Lymphoma & Myeloma 2019 International Congress 21.6%

4/20 Verastem Oncology Announces Investor Conference Call to Discuss Clinical Data from Investigator-initiated RAF/MEK and FAK Combination Study in KRAS Mutant Solid Tumors 21.3%

2/3 Form SC 13G Verastem, Inc. Filed by: Point72 Asset Management, L.P. 14.2%

4/21 Form DEFA14A Verastem, Inc. 13.2%

3/5 Form 3 Verastem, Inc. For: Mar 03 Filed by: Kolchinsky Peter 12.3%

7/10 Form SC 13G/A Verastem, Inc. Filed by: BlackRock Inc. 10.7%

5/10 Verastem Inc (NASDAQ: VSTM) had its price target lowered by analysts at BTIG Research to $8.00. They now have a "buy" rating on the stock. 9.5%

Top News Decliners

4/27 Verastem Oncology Announces Preliminary Data from Investigator-initiated Study Highlighting Clinical Activity of RAF/MEK and FAK Combination in KRAS Mutant Tumors Presented at the American Association for Cancer Research 2020 Virtual Annual Meeting I -51.4%

5/9 Q1/2019 3/31/2019 EPS -0.520 ZacksConsensus -0.460 ActVsEst (0.060) - Miss -28.8%

3/11 Form 10-K Verastem, Inc. For: Dec 31 -26.1%

6/20 Verastem Oncology Announces Leadership Changes -17.2%

3/16 Verastem Inc (NASDAQ: VSTM) had its price target raised by analysts at HC Wainwright from $2.50 to $2.75. They now have a "buy" rating on the stock. -16.8%

8/1 Form 8-K Verastem, Inc. For: Jul 29 -16.7%

3/6 Form SC 13G/A Verastem, Inc. Filed by: Ridgeback Capital Investments L.P. -16.0%

10/29 Q3/2019 9/30/2019 EPS -0.350 ZacksConsensus -0.420 ActVsEst 0.070 - Beat -14.3%

4/28 Verastem Inc (NASDAQ: VSTM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $2.75 price target on the stock. -14.2%

4/23 Form 8-K Verastem, Inc. For: Apr 23 -10.3%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day